2004
DOI: 10.1016/j.ejphar.2004.03.050
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 41 publications
0
7
0
Order By: Relevance
“…These receptors belong to the superfamily of seven transmembrane spanning receptors that couple to G-proteins (Chen et al, 1993), but some studies have suggested that heroin and morphine may act by differential mechanisms (Rady et al, 1991), and suggest the possibility that an alternative splice variant of the cloned mu opioid receptor may be responsible for the analgesic actions of heroin (Gilbert et al, 2004;Schuller et al, 1999). Chronic heroin use produces high levels of tolerance and physical dependence, but the biological mechanisms, which mediate these effects in brain, are still not clear.…”
Section: Introductionmentioning
confidence: 98%
“…These receptors belong to the superfamily of seven transmembrane spanning receptors that couple to G-proteins (Chen et al, 1993), but some studies have suggested that heroin and morphine may act by differential mechanisms (Rady et al, 1991), and suggest the possibility that an alternative splice variant of the cloned mu opioid receptor may be responsible for the analgesic actions of heroin (Gilbert et al, 2004;Schuller et al, 1999). Chronic heroin use produces high levels of tolerance and physical dependence, but the biological mechanisms, which mediate these effects in brain, are still not clear.…”
Section: Introductionmentioning
confidence: 98%
“…It has also been reported that one of heroin metabolites, 6-MAM, possesses higher efficacy than other heroin metabolites at mu-opioid receptors, which may contribute to the higher efficacy of heroin compared with morphine in certain behavioral paradigms in vivo (Selley et al, 2001). And systemically administrated heroin and its active metabolite, 6-MAM, were significantly more potent than all the other derivatives, including morphine in analgesic test (Gilbert et al, 2004). These above reports seem to give us the hint that heroin metabolites, especially the 6-MAM, might be mainly responsible for the differential effect between morphine and heroin.…”
Section: Discussionmentioning
confidence: 75%
“…Antioligodeoxynucleotides targeting exon 2 of the MOR-1 gene can decrease heroin and M6G analgesia, but not morphine (Rossi et al, 1996), and, conversely, the deletion of exon 1 effectively lowers morphine analgesia but has no effect on heroin and M6G (Matthes et al, 1996;Schuller et al, 1999). Finally, heroin and morphine show an incomplete cross-tolerance owing to the maintenance of heroin analgesic activity in a mouse model of morphine tolerance (Lange et al, 1980;Rossi et al, 1996;Gilbert et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…In general, previous work in the literature does not provide a good framework to rationalize the effect of modifying positions 7 and 8. Reduction of the 7,8 double bond in morphine, leading to dihydromorphine, increases activity approximately by two fold at the DOR and MOR, but decreases it at the KOR by 8-fold [53][54][55]. When comparing dihydrocodeine to codeine (8), the activity is in contrast decreasing at DOR and KOR (respectively 6-and 2-fold) and increasing 8.5-fold at MOR [56].…”
Section: Structure-activity Relationshipsmentioning
confidence: 97%